SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia

Hooshyar, Samira Hosseini; Martinello, Marianne; Yee, Jasmine; Bartlett, Sofia; Read, Phillip; Baker, David; Post, Jeffrey J.; Finlayson, Robert; Bloch, Mark; Doyle, Joseph P.; Shaw, David; Hellard, Margaret; Petoumenos, Kathy; Marks, Pip; Applegate, Tanya; Dore, Gregory J.; Matthews, Gail

doi:10.1016/s0618-8278(19)31468-9

Search citation statements

Order By: Relevance

Paper Sections

Select...

Why Was the Consortium Set Up?1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2023

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 28–30 Reinfection rates reported by single-country studies after DAA introduction vary, depending on the populations engaged in certain behaviours associated with HCV and potentially on the methodology used. 27 , 28 , 31 , 32 For example, among people who inject drugs, a stable reinfection incidence was observed in Canada but increases were observed in Scotland. 28 , 32 …”

Section: Why Was the Consortium Set Up?mentioning

confidence: 99%